# A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand

> **NCT03302858** · PHASE2 · UNKNOWN · sponsor: **Stephen E. Goldstone** · enrollment: 70 (estimated)

## Conditions studied

- HSIL, High Grade Squamous Intraepithelial Lesions
- Anal Cancer
- HPV-Related Squamous Cell Carcinoma
- Human Papilloma Virus
- Human Papillomavirus Infection
- Ain III

## Interventions

- **DEVICE:** BARRX™ Anorectal Wand

## Key facts

- **NCT ID:** NCT03302858
- **Lead sponsor:** Stephen E. Goldstone
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10
- **Primary completion:** 2019-10
- **Final completion:** 2020-10
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03302858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03302858, "A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03302858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*